Back to Search
CHARLES DAI, M.D.
M.D.
Anesthesiology Physician
NPI: 1730135401IndividualAccepts Medicare
Education
OTHER
Class of 1985
Research & Publications (20)
Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control.
PMID 19625081·Biomaterials·2009
7-preclinical
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
PMID 19231011·J Hepatol·2009
8-other
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
PMID 19232821·Cancer Lett·2009
8-other
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
PMID 19410561·Biochem Pharmacol·2009
7-preclinical
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.
PMID 18940717·Transl Res·2008
8-other
[Resection of centrally located primary liver cancer].
PMID 18795621·Zhongguo Yi Xue Ke Xue Yuan Xue Bao·2008
8-other
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
PMID 18829547·Cancer Res·2008
7-preclinical
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study.
PMID 18486265·J Hepatol·2008
8-other
[Mutation screening of the TYR and P gene in three patients with oculocutaneous albinism].
PMID 18683130·Zhonghua Yi Xue Yi Chuan Xue Za Zhi·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 S MAIN ST
CORONA, CA 92882 - Phone
- (951) 737-4343
Quick Facts
- NPI
- 1730135401
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile